Idiopathic progressive sensorineural hearing loss in children.

[1]  C. Papageorgiou,et al.  Neurophysiological and neuro‐otological study of homozygous beta‐thalassemia under long‐term desferrioxamine (DFO) treatment , 1991, Acta Neurologica Scandinavica.

[2]  A. Cohen,et al.  Vision and hearing during deferoxamine therapy. , 1990, The Journal of pediatrics.

[3]  J. Hazell,et al.  Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage , 1989, British journal of haematology.

[4]  A. Adekile,et al.  Sensorineural Hearing Loss in Children with Sickle Cell Anemia , 1987, The Annals of otology, rhinology, and laryngology.

[5]  J. Kanzaki,et al.  Bilateral progressive sensorineural hearing loss of unknown etiology. , 1981, ORL; journal for oto-rhino-laryngology and its related specialties.

[6]  G. Herer,et al.  Sickle Cell Anemia and Hearing , 1980, Annals of Otology, Rhinology and Laryngology.

[7]  D. Orchik,et al.  Auditory function in sickle cell anemia. , 1978, Archives of otolaryngology.

[8]  T. Tsuiki.  ETIOLOGICAL CONSIDERATIONS ON THE SENSORINEURAL HEARING LOSS , 1976 .

[9]  George E. Urban.  Reversible sensori‐neural hearing loss associated with sickle cell crisis , 1973, The Laryngoscope.